Shiyao Jingfeng released its 2026 interim report, with net profit attributable to the parent company of 5.87 million yuan, an increase of 38.44 million yuan compared with the same period last year, turning losses into profits. The company's total operating revenue was 202 million yuan, up 10.36 percent year on year. Net cash outflow from operating activities was 125 million yuan, an increase of 123 million yuan compared with the same period last year. The company's latest asset-liability ratio was 16.58 percent, down 88.65 percentage points from the same period last year.
Hunan Jingfeng PharmaceuticalCompany turned profitable with net profit of 5.87 million yuan, up 38.44 million year-on-year.
